hrs4r
 I want to donate

JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS

Firma
JOSÉ MANUEL FERNÁNDEZ-REAL-LEMOS
Position
Cap de Grup - R4
Group leader - R4

Projectes

Codi oficial: PI18/01022 Start date:01/01/2019 Data fi: 30/06/2022 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 307,642.50 €
Codi oficial: PI19/01712 Start date:01/01/2020 Data fi: 31/12/2022 Investigador/a principal: JOSE MARIA MORENO NAVARRETE Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 277,090 €
Codi oficial: 875534 Start date:09/07/2020 Data fi: 08/07/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: EUROPEAN COMISSION Ajuda: 300,000 €
Codi oficial: AC18/00012 Start date:01/01/2019 Data fi: 30/06/2023 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 149,998.86 €
Codi oficial: FI19/00293 Start date:01/01/2020 Data fi: 31/12/2023 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 82,400 €
Codi oficial: INT19/00013 Start date:01/01/2020 Data fi: 31/12/2021 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 60,000 €
Codi oficial: CM19/00190 Start date:01/01/2020 Data fi: 31/12/2021 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 53,732 €
Codi oficial: CD20/00051 Start date:01/01/2021 Data fi: 31/12/2023 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 80,598 €
Codi oficial: EFA345/19 Start date:01/04/2020 Data fi: 31/05/2022 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: CONSORCIO DE LA CTP. INTERREG POCTEFA Ajuda: 599,974.98 €
Codi oficial: SMARTAGE Start date:01/09/2020 Data fi: 31/08/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: EUROPEAN COMISSION Ajuda: 417,569.76 €
Codi oficial: 19/0006059 Start date:03/02/2020 Data fi: 02/02/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: DIABETES UK Ajuda: 0 €
Codi oficial: METASUCC Start date:01/12/2020 Data fi: 31/12/2023 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: FUND. BANCARIA "LA CAIXA" Ajuda: 258,752.50 €
Codi oficial: SLT017/20/000164 Start date:12/07/2021 Data fi: 31/12/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: GENERALITAT DE CATALUNYA Ajuda: 92,623.53 €
Codi oficial: UKRI Cognitive Decline Start date:01/01/2022 Data fi: 31/12/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: UK RESEARCH AND INNOVATION (UKRI) Ajuda: 0 €

Publicacions

Rodríguez-Hermosa JI, Delisau O, Planellas-Giné P, Cornejo L, Ranea A, Maldonado E, Fernández-Real JM, Codina-Cazador A

Factors associated with prolonged hospital stay after laparoscopic adrenalectomy.

Updates in Surgery, 2021, 73, 693-702 dx.doi.org/10.1007/s13304-020-00880-w

Moreno-Navarrete JM, Latorre J, Lluch A, Ortega FJ, Comas F, Arnoriaga-Rodríguez M, Ricart W, Fernández-Real JM

Lysozyme is a component of the innate immune system linked to obesity associated-chronic low-grade inflammation and altered glucose tolerance.

CLINICAL NUTRITION, 2021, 40, 1420-1429 dx.doi.org/10.1016/j.clnu.2020.08.036

Comas F, Latorre J, Ortega F, Arnoriaga Rodríguez M, Lluch A, Sabater M, Rius F, Ribas X, Costas M, Ricart W, Lecube A, Fernández-Real JM, Moreno-Navarrete JM

Morbidly obese subjects show increased serum sulfide in proportion to fat mass.

INTERNATIONAL JOURNAL OF OBESITY, 2021, 45, 415-426 dx.doi.org/10.1038/s41366-020-00696-z

Avari P, Leal Y, Herrero P, Wos M, Jugnee N, Arnoriaga-Rodríguez M, Thomas M, Liu C, Massana Q, Lopez B, Nita L, Martin C, Fernandez-Real JM, Oliver N, Fernandez M, Reddy M

Safety and feasibility of the PEPPER adaptive bolus advisor and safety system; a randomized control study.

DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23, 175-186 dx.doi.org/10.1089/dia.2020.0301

Comas F, Latorre J, Ortega F, Oliveras-Cañellas N, Lluch A, Ricart W, Fernández-Real JM, Moreno-Navarrete JM

Permanent cystathionine-ß-Synthase gene knockdown promotes inflammation and oxidative stress in immortalized human adipose-derived mesenchymal stem cells, enhancing their adipogenic capacity.

Redox Biology, 2021, 42, 101668-101668 dx.doi.org/10.1016/j.redox.2020.101668

Fernández-Real JM, Mayneris-Perxachs J

Is the jejunum the fulcrum of glucose metabolism?

Gut, 2021, 70, 1005-1006 dx.doi.org/10.1136/gutjnl-2020-322662

Morón-Ros S, Uriarte I, Berasain C, Avila MA, Sabater-Masdeu M, Moreno-Navarrete JM, Fernández-Real JM, Giralt M, Villarroya F, Gavaldà-Navarro A

FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations.

Molecular Metabolism, 2021, 43, 101113-101113 dx.doi.org/10.1016/j.molmet.2020.101113

Escrichs A, Biarnes C, Garre-Olmo J, Fernández-Real JM, Ramos R, Pamplona R, Brugada R, Serena J, Ramió-Torrentà L, Coll-De-Tuero G, Gallart L, Barretina J, Vilanova JC, Mayneris-Perxachs J, Essig M, Figley CR, Pedraza S, Puig J, Deco G

Whole-Brain Dynamics in Aging: Disruptions in Functional Connectivity and the Role of the Rich Club.

CEREBRAL CORTEX, 2021, 31, 2466-2481 dx.doi.org/10.1093/cercor/bhaa367

Garre-Olmo J, Turró-Garriga O, Martí-Lluch R, Zacarías-Pons L, Alves-Cabratosa L, Serrano-Sarbosa D, Vilalta-Franch J, Ramos R, Girona Healthy Region Study Group

Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study.

COMPREHENSIVE PSYCHIATRY, 2021, 104, 152214-152214 dx.doi.org/10.1016/j.comppsych.2020.152214

Izquierdo AG, Carreira MC, Rodriguez-Carnero G, Fernandez-Quintela A, Sueiro AM, Martinez-Olmos MA, Guzman G, De Luis D, Pinhel MAS, Nicoletti CF, Nonino CB, Ortega FJ, Portillo MP, Fernandez-Real JM, Casanueva FF, Crujeiras AB

Weight loss normalizes enhanced expression of the oncogene survivin in visceral adipose tissue and blood leukocytes from individuals with obesity.

INTERNATIONAL JOURNAL OF OBESITY, 2021, 45, 206-216 dx.doi.org/10.1038/s41366-020-0630-7

Propietat intel·lectual

José Manuel Fernández-real Lemos

METHOD FOR DIAGNOSING HEPATIC FIBROSIS

Número de publicació: WO2015162200 Data de publicació: 2015-10-29

José Manuel Fernández-real Lemos

METHOD FOR DIAGNOSING HEPATIC FIBROSIS BASED ON BACTERIAL PROFILE AND DIVERSITY

Número de publicació: WO2017060039 Data de publicació: 2018-08-15

José Manuel Fernández-real Lemos

METHODS FOR DETERMINING WHETHER A SUBJECT HAS OR IS AT RISK OF HAVING A NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR ONE OF ITS COMPLICATIONS

Número de publicació: WO2019077125 Data de publicació: 2019-04-25

Formulari de contacte

About IDIBGI!

menu